Chapter 1 Prefix
    1.1 Market Scope
    1.2 Report Description
    1.3 Research Methodology
          1.3.1 Primary Research
          1.3.2 Secondary Research
          1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
Chapter 3 Market Outline
    3.1 Market Inclination, Trend, Outlook and Viewpoint
    3.2 Market Share Analysis: Company’s Competitive Scenario
    3.3 Market Dynamics
          3.3.1 Drivers
                   3.3.1.1 Impact Analysis
          3.3.2 Restraints
                   3.3.2.1 Impact Analysis
          3.3.3 Opportunities
Chapter 4 Depression Drug Market by Type: Market Size and Forecast, 2015 – 2024
    4.1 Overview
    4.2 Anticonvulsants
          4.2.1 Current Trend and Analysis
          4.2.2 Market Size and Forecast
    4.3 Serotonin-norepinephrine reuptake inhibitors (SNRIs)
          4.3.1 Current Trend and Analysis
          4.3.2 Market Size and Forecast
    4.4 Beta-blockers
          4.4.1 Current Trend and Analysis
          4.4.2 Market Size and Forecast
    4.5 Benzodiazepines
          4.5.1 Current Trend and Analysis
          4.5.2 Market Size and Forecast
    4.6 Tetracyclic antidepressants (TeCAs)
          4.6.1 Current Trend and Analysis
          4.6.2 Market Size and Forecast
    4.7 Selective serotonin reuptake inhibitors (SSRIs)
          4.7.1 Current Trend and Analysis
          4.7.2 Market Size and Forecast
    4.8 Monoamine oxidase inhibitors (MAOIs)
          4.8.1 Current Trend and Analysis
          4.8.2 Market Size and Forecast
Chapter 5 Depression Drug Market by Application: Market Size and Forecast, 2015 – 2024
    5.1 Overview
    5.2 Clinics and Hospitals
          5.2.1 Current Trend and Analysis
          5.2.2 Market Size and Forecast
    5.3 Research Centers
          5.3.1 Current Trend and Analysis
          5.3.2 Market Size and Forecast
Chapter 6 Depression Drug Market by Geography: Market Size and Forecast, 2015 – 2024
    6.1 Overview
    6.2 North America
          6.2.1 Current Trend and Analysis
          6.2.2 Market Size and Forecast
          6.2.3 US
                   6.2.3.1 Market Size and Forecast
          6.2.4 Canada
                   6.2.4.1 Market Size and Forecast
          6.2.5 Mexico
                   6.2.5.1 Market Size and Forecast
    6.3 Europe
          6.3.1 Current Trend and Analysis
          6.3.2 Market Size and Forecast
          6.3.3 Germany
                   6.3.3.1 Market Size and Forecast
          6.3.4 France
                   6.3.4.1 Market Size and Forecast
          6.3.5 United Kingdom
                   6.3.5.1 Market Size and Forecast
          6.3.6 Rest of Europe
                   6.3.6.1 Market Size and Forecast
    6.4 Asia-Pacific
          6.4.1 Current Trend and Analysis
          6.4.2 Market Size and Forecast
          6.4.3 China
                   6.4.3.1 Market Size and Forecast
          6.4.4 India
                   6.4.4.1 Market Size and Forecast
          6.4.5 Japan
                   6.4.5.1 Market Size and Forecast
          6.4.6 Australia
                   6.4.6.1 Market Size and Forecast
          6.4.7 Rest of Asia-Pacific
                   6.4.7.1 Market Size and Forecast
    6.5 RoW
          6.5.1 Current Trend and Analysis
          6.5.2 Market Size and Forecast
          6.5.3 The Middle East
                   6.5.3.1 Market Size and Forecast
          6.5.4 South America
                   6.5.4.1 Market Size and Forecast
          6.5.5 Africa
                   6.5.5.1 Market Size and Forecast
Chapter 7 Company Profiles
    7.1 H.Lundbeck, Merck & Co.
    7.2 SK Biopharmaceuticals
    7.3 Novartis
    7.4 AstraZeneca.
    7.5 Forest Laboratories
    7.6 Naurex
    7.7 GlaxoSmithKline
    7.8  Eli Lilly and Co.
List of Figures
FIG. 1 MARKET SEGMENTATION: GLOBAL DEPRESSION DRUGS MARKET
FIG. 2 MARKET SHARE ANALYSIS, 2016 (%)
FIG. 3 GLOBAL DEPRESSION DRUGS MARKET SHARE AND FORECAST, BY TYPE 2016 Vs 2024 (VALUE %)
FIG. 4 TRICYCLICE ANTIDEPRESSANTS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 5 SEROTONIN-NOREPINEPHRINE INHIBITORS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 6 ATYPICAL ANTIPSYCHOTICS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 7 SELECTIVE SEROTONIN REUPTAKE INHIBITORS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 8 BENZODIAZEPINES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 9 TETRACYCLIC ANTIDEPRESSANTS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 10 MONOAMINE OXIDASE INHIBITORS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 11 OTHER PRODUCT TYPE MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 12 GLOBAL DEPRESSION DRUGS MARKET SHARE AND FORECAST, BY INDUSRTY VERTICAL, 2016 VS. 2024 (VALUE %)
FIG. 13 CLINICS AND HOSPITALS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 14 RESEARCH CENTRES MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 15 GLOBAL DEPRESSION DRUGS MARKET SIZE AND FORECAST BY GEOGRAPHY, 2016 Vs 2024 (REVENUE, CAGR %)
FIG. 16 NORTH AMERICA DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 17 NORTH AMERICA DEPRESSION DRUGS MARKET SIZE AND FORECAST BY COUNTRY, 2015 – 2024 ($ BILLION)
FIG. 18 U.S. DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 19 CANADA DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 20 MEXICO DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 21 EUROPE DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 BY COUNTRY, ($ BILLION)
FIG. 22 U.K. DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 23 FRANCE DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 24 GERMANY DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 25 OTHERS DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 26 ASIA-PACIFIC DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 BY COUNTRY ($ BILLION)
FIG. 27 CHINA DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 28 INDIA DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 29 JAPAN DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 30 OTHERS DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 31 REST OF THE WORLD DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 BY COUNTRY ($ BILLION)
FIG. 32 SOUTH AMERICA DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 33 MIDDLE EAST DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
FIG. 34 AFRICA DEPRESSION DRUGS MARKET SIZE AND FORECAST, 2015 – 2024 ($ BILLION)
List of Tables
TABLE 1 GLOBAL DEPRESSION DRUGS MARKET SNAPSHOT
TABLE 2 GLOBAL DEPRESSION DRUGS MARKET SIZE AND FORECAST, BY REGION, 2015 – 2024 ($ BILLION)
TABLE 3 DRIVER OF THE GLOBAL DEPRESSION DRUGS MARKET: IMPACT ANALYSIS
TABLE 4 RESTRAINTS OF THE GLOBAL DEPRESSION DRUGS MARKET: IMPACT ANALYSIS
TABLE 5 TRICYCLICE ANTIDEPRESSANTS MARKET SIZE AND FORECAST, BY REGIONS, 2015 – 2024 ($ BILLION)
TABLE 6 SEROTONIN-NOREPINEPHRINE INHIBITORS MARKET SIZE AND FORECAST, BY REGIONS, 2015 – 2024 ($ BILLION)
TABLE 7 ATYPICAL ANTIPSYCHOTICS MARKET SIZE AND FORECAST, BY REGIONS, 2015 – 2024 ($ BILLION)
TABLE 8 SELECTIVE SEROTONIN REUPTAKE INHIBITORS MARKET SIZE AND FORECAST, BY REGIONS, 2015 – 2024 ($ BILLION)
TABLE 9 BENZODIAZEPINES MARKET SIZE AND FORECAST, BY REGIONS, 2015 – 2024 ($ BILLION)
TABLE 10 TETRACYCLIC ANTIDEPRESSANTS MARKET SIZE AND FORECAST, BY REGIONS, 2015 – 2024 ($ BILLION)
TABLE 11 MONOAMINE OXIDASE INHIBITORS MARKET SIZE AND FORECAST, BY REGIONS, 2015 – 2024 ($ BILLION)
TABLE 12 OTHER PRODUCT TYPE MARKET SIZE AND FORECAST, BY REGIONS, 2015 – 2024 ($ BILLION)
TABLE 13 CLINICS AND HOSPITALS MARKET SIZE AND FORECAST, BY REGIONS, 2015 – 2024 ($ BILLION)
TABLE 14 RESEARCH CENTRES MARKET SIZE AND FORECAST, BY REGIONS, 2015 – 2024 ($ BILLION)
TABLE 15 NORTH AMERICA DEPRESSION DRUGS MARKET SIZE AND FORECAST, BY PRODUCT TYPE, 2015 – 2024 ($ BILLION)
TABLE 16 NORTH AMERICA DEPRESSION DRUGS MARKET SIZE AND FORECAST, BY APPLICATION, 2015 – 2024 ($ BILLION)
TABLE 17 EUROPE DEPRESSION DRUGS MARKET SIZE AND FORECAST, BY PRODUCT TYPE, 2015 – 2024 ($ BILLION)
TABLE 18 EUROPE DEPRESSION DRUGS MARKET SIZE AND FORECAST, BY APPLICATION, 2015 – 2024 ($ BILLION)
TABLE 19 ASIA-PACIFIC DEPRESSION DRUGS MARKET SIZE AND FORECAST, BY PRODUCT TYPE, 2015 – 2024 ($ BILLION)
TABLE 20 ASIA-PACIFIC DEPRESSION DRUGS MARKET SIZE AND FORECAST, BY APPLICATION, 2015 – 2024 ($ BILLION)
TABLE 21 REST OF THE WORLD DEPRESSION DRUGS MARKET SIZE AND FORECAST, BY PRODUCT TYPE, 2015 – 2024 ($ BILLION)
TABLE 22 REST OF THE WORLD DEPRESSION DRUGS MARKET SIZE AND FORECAST, BY APPLICATION, 2015 – 2024 ($ BILLION)
TABLE 23 GLAXOSMITHKLINE: COMPANY SNAPSHOT
TABLE 24 H. LUNDBECK: COMPANY SNAPSHOT
TABLE 25 SK BIOPHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 26 NOVARTIS: COMPANY SNAPSHOT
TABLE 27 ASTRAZENECA: COMPANY SNAPSHOT
TABLE 28 FOREST LABORATORIES: COMPANY SNAPSHOT
TABLE 29 NAUREX: COMPANY SNAPSHOT
TABLE 30 ELI LILLY AND CO.: COMPANY SNAPSHOT
TABLE 31 MERCK & CO.: COMPANY SNAPSHOT
TABLE 32 PFIZER INC.: COMPANY SNAPSHOT
Related Report
Clinical Nutrition Market (By Product: Infant Nutrition, Enteral Nutrition, and Parenteral Nutrition; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015 – 2024
- November 2017
Connected Wearable Patches Market Global Scenario Market Size, Outlook, Trend and Forecast, 2016 – 2024
- January 1970
Regenerative Medicine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015 – 2024
- December 2017
Cold Pain Therapy Market (By Product: OTC-Based Products (Pharmaceuticals And Medical Devices) And Prescription Based Products (Motorized Devices and Non-Motorized Devices); By Application: Musculoskeletal Disorder, Sport Medicine, Post-Operative, Post-Trauma, And Physical Therapy; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024
- September 2017
Orthopedic Soft Tissue Repair and Sports Medicine Market (By Surgical Procedures: ACL/PCL, Meniscal Repair, Rotator Cuff, Shoulder Labarum, Hip Arthroscopy, Biceps Tenodesis; By Injury Location: Knee, Hip, Shoulder, And Others; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024
- September 2017